A new study reveals that the world’s most widely used diabetes drug works through a previously unknown brain pathway ...
HONOLULU — Glovadalen (UCB), an investigational brain-penetrant D1 receptor positive allosteric modulator (D1 PAM), is both safe and effective for patients with advanced Parkinson’s disease (PD), new ...
A new study headed by teams at the Wellcome Sanger Institute, EMBL’s European Bioinformatics Institute (EMBL-EBI), and Open Targets has indicated how mutations that cause cancer drug resistance fall ...
Neuroinflammation drives the progression of neurodegenerative disorders like Alzheimer's, Parkinson's, and multiple sclerosis ...
Ten structures of URAT1 obtained by scientists provide a deep understanding of the mechanism of urate transport to guide gout therapeutic design. Scientists at St. Jude Children's Research Hospital ...
The changing natural and social environments, coupled with pathogen mutations, have led to a spike in the emergence of new infectious diseases. This presents a severe medical challenge for the world.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results